GLP-1 side effects on TikTok: what's accurate and what's off

What did @aubergine_avenger actually say?

The creator argues that tesofensine is "one of the most underrated" weight-loss compounds because, unlike retatrutide, it works "on the old noggin" by boosting serotonin, dopamine, and norepinephrine simultaneously. Their core claim: tesofensine suppresses appetite at the brain level rather than slowing the gut, keeps focus sharp, and produces energy through norepinephrine. They also flag, correctly, that combining it with an SSRI is worth serious caution.

They explicitly say tesofensine and retatrutide are "not the fucking same thing," which is at least honest framing. The argument is that both work for fat loss through fundamentally different mechanisms, and the video is clearly pitched at people who want cognitive sharpness alongside weight loss, not the nausea-and-constipation GLP-1 experience.

Does the science back this up?

Partially, yes. The core mechanism claim is accurate enough. Tesofensine is a triple monoamine reuptake inhibitor, blocking reuptake of serotonin, dopamine, and norepinephrine. Phase 2 trial data (Astrup et al., 2008, The Lancet) showed 0.5 mg/day produced roughly 10% body weight loss over 24 weeks, which was meaningfully higher than placebo and competitive with drugs available at the time.

The "brain not stomach" framing is a reasonable simplification. Tesofensine's primary mechanism is central, acting on hypothalamic appetite circuits, unlike GLP-1 agonists which work substantially through gut-brain signaling and direct gastric effects. However, calling it a clean cognitive enhancer is overselling it. The norepinephrine boost does increase energy expenditure and can improve alertness, but the same mechanism drives the well-documented side effect profile: elevated heart rate, blood pressure, dry mouth, insomnia, and jitteriness. Those are not minor footnotes. The Astrup trial reported dropout rates due to adverse events that were non-trivial at higher doses.

What did they get wrong (or right)?

They got the mechanism directionally right but glossed over the cardiovascular risk in a way that matters. Tesofensine's norepinephrine activity raises heart rate and blood pressure, which is why it never made it past Phase 2 to regulatory approval. Framing norepinephrine as just making you "like Johnny Storm, flame on" and skipping the hypertension signal is a real omission for a 119K-view audience.

The SSRI warning deserves credit. Serotonin syndrome risk from combining a triple reuptake inhibitor with an SSRI is a legitimate clinical concern, and they called it out without being prompted. That's better than most supplement influencers manage.

• Right: triple monoamine mechanism described accurately
• Right: SSRI contraindication flagged
• Right: explicit disclaimer that these two compounds are not the same
• Wrong: no mention of blood pressure or heart rate elevation
• Wrong: "your brain stays sharp" overstates cognitive benefit evidence
• Wrong: framing tesofensine as broadly available and straightforward ignores that it has no regulatory approval in the US, EU, or UK for any indication

What should you actually know?

Tesofensine is not approved by the FDA, EMA, or MHRA. It exists in a grey zone, available through compounding pharmacies in some jurisdictions, but without the post-market safety data that comes with approved drugs. That does not make it automatically dangerous, but it does mean the long-term cardiovascular signal has never been fully characterized in large populations.

The Lancet Phase 2 data is real and the weight-loss numbers are legitimate. But Phase 2 is not Phase 3, and tesofensine's development was shelved partly because the benefit-risk ratio at effective doses was not clean enough for regulators. A 2023 review (Srivastava et al., 2023, Obesity Reviews) noted that norepinephrine-heavy agents as a class carry persistent cardiovascular concerns that have historically limited approval, pointing to sibutramine's post-market withdrawal as the cautionary example.

If you are considering tesofensine through any channel, the conversation you need to have with a prescriber includes your baseline blood pressure, resting heart rate, any history of cardiovascular disease, and a full medication review. The "it energizes you" effect and the "it can stress your heart" effect come from the same pathway.

Bottom line

This video is more mechanistically accurate than most weight-loss content at this view count. The brain-versus-gut framing is a reasonable simplification, not a fabrication. But the omission of cardiovascular risk data and the zero context around regulatory status means a viewer walks away with a rosier picture than the clinical record supports. Credit where it is due, reject where it matters.